Berry Global (BERY) 10-Q 5 Aug 21 2021 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares shares in Millions	9 Months Ended
	Jul. 03, 2021	Aug. 05, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Period End Date	Jul. 3, 2021
Current Fiscal Year End Date	--10-02
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Document Transition Report	false
Entity File Number	001-35672
Entity Registrant Name	BERRY GLOBAL GROUP, INC.
Entity Central Index Key	0001378992
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	101 Oakley Street
Entity Address, City or Town	Evansville
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	47710
City Area Code	812
Local Phone Number	424-2904
Entity Tax Identification Number	20-5234618
Title of 12(b) Security	Common Stock, $0.01 par value per share
Trading Symbol	BERY
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		135.3

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 03, 2021	Jun. 27, 2020	Jul. 03, 2021	Jun. 27, 2020
Consolidated Statements of Income [Abstract]
Net sales	$ 3,675	$ 2,910	$ 10,181	$ 8,701
Costs and expenses:
Cost of goods sold	3,049	2,272	8,273	6,959
Selling, general and administrative	207	198	668	631
Amortization of intangibles	72	74	219	226
Restructuring and transaction activities	4	19	41	55
Operating income	343	347	980	830
Other expense, net	14	(7)	45	6
Interest expense, net	76	110	257	339
Income before income taxes	253	244	678	485
Income tax expense	59	53	173	121
Net income	$ 194	$ 191	$ 505	$ 364
Net income per share:
Basic (in dollars per share)	$ 1.44	$ 1.44	$ 3.76	$ 2.75
Diluted (in dollars per share)	$ 1.40	$ 1.42	$ 3.67	$ 2.71

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 03, 2021	Jun. 27, 2020	Jul. 03, 2021	Jun. 27, 2020
Consolidated Statements of Comprehensive Income [Abstract]
Net income	$ 194	$ 191	$ 505	$ 364
Other comprehensive income (loss), net of tax:
Currency translation	91	11	196	(54)
Pension	0	0	0	(1)
Derivative instruments	(2)	(13)	69	(109)
Other comprehensive income (loss)	89	(2)	265	(164)
Comprehensive income	$ 283	$ 189	$ 770	$ 200

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Jul. 03, 2021	Sep. 26, 2020
Current assets:
Cash and cash equivalents	$ 804	$ 750
Accounts receivable, net	1,851	1,469
Finished goods	913	708
Raw materials and supplies	822	560
Prepaid expenses and other current assets	198	168
Assets held for sale	0	162
Total current assets	4,588	3,817
Noncurrent assets:
Property, plant and equipment	4,731	4,561
Goodwill and intangible assets	7,599	7,670
Right-of-use assets	577	562
Other assets	82	91
Total assets	17,577	16,701
Current liabilities:
Accounts payable	1,556	1,115
Accrued employee costs	327	324
Other current liabilities	771	644
Current portion of long-term debt	225	75
Liabilities held for sale	0	25
Total current liabilities	2,879	2,183
Noncurrent liabilities:
Long-term debt, less current portion	9,469	10,162
Deferred income taxes	546	601
Employee benefit obligations	354	368
Operating lease liabilities	480	464
Other long-term liabilities	896	831
Total liabilities	14,624	14,609
Stockholders' equity:
Common stock (135.4 and 133.6 million shares issued, respectively)	1	1
Additional paid-in capital	1,125	1,034
Retained earnings	2,113	1,608
Accumulated other comprehensive loss	(286)	(551)
Total stockholders' equity	2,953	2,092
Total liabilities and stockholders' equity	$ 17,577	$ 16,701

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - shares shares in Millions	Jul. 03, 2021	Sep. 26, 2020
Stockholders' equity:
Common stock, shares issued (in shares)	135.4	133.6

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Millions		Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Retained Earnings [Member]	Total	Adjustment for Adoption of New Accounting Standard [Member]Common Stock [Member]	Adjustment for Adoption of New Accounting Standard [Member]Additional Paid-in Capital [Member]	Adjustment for Adoption of New Accounting Standard [Member]Accumulated Other Comprehensive Loss [Member]	Adjustment for Adoption of New Accounting Standard [Member]Retained Earnings [Member]	Adjustment for Adoption of New Accounting Standard [Member]
Balance at Sep. 28, 2019		$ 1	$ 949	$ (386)	$ 1,054	$ 1,618
Balance (ASU 2016-02 Related to Leases [Member]) at Sep. 28, 2019							$ 0	$ 0	$ 0	$ (5)	$ (5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		0	0	0	364	364
Other comprehensive income (loss)		0	0	(164)	0	(164)
Share-based compensation		0	28	0	0	28
Proceeds from issuance of common stock		0	6	0	0	6
Acquisition	[1]	0	22	0	0	22
Balance at Jun. 27, 2020		1	1,005	(550)	1,413	1,869
Balance at Mar. 28, 2020		1	976	(548)	1,222	1,651
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		0	0	0	191	191
Other comprehensive income (loss)		0	0	(2)	0	(2)
Share-based compensation		0	4	0	0	4
Proceeds from issuance of common stock		0	3	0	0	3
Acquisition	[1]	0	22	0	0	22
Balance at Jun. 27, 2020		1	1,005	(550)	1,413	1,869
Balance at Sep. 26, 2020		1	1,034	(551)	1,608	2,092
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		0	0	0	505	505
Other comprehensive income (loss)		0	0	265	0	265
Share-based compensation		0	34	0	0	34
Proceeds from issuance of common stock		0	57	0	0	57
Balance at Jul. 03, 2021		1	1,125	(286)	2,113	2,953
Balance at Apr. 03, 2021		1	1,101	(375)	1,919	2,646
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		0	0	0	194	194
Other comprehensive income (loss)		0	0	89	0	89
Share-based compensation		0	6	0	0	6
Proceeds from issuance of common stock		0	18	0	0	18
Balance at Jul. 03, 2021		$ 1	$ 1,125	$ (286)	$ 2,113	$ 2,953
[1]	Represents noncontrolling interest

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Jul. 03, 2021	Jun. 27, 2020
Cash Flows from Operating Activities:
Net income	$ 505	$ 364
Adjustments to reconcile net cash provided by operating activities:
Depreciation	420	412
Amortization of intangibles	219	226
Non-cash interest	26	18
Deferred income tax	(53)	30
Share-based compensation expense	34	28
Other non-cash operating activities, net	60	23
Changes in working capital	(278)	(93)
Changes in other assets and liabilities	(21)	(29)
Net cash from operating activities	912	979
Cash Flows from Investing Activities:
Additions to property, plant and equipment, net	(520)	(419)
Divestitures	165	0
Settlement of net investment hedges	0	281
Other	0	(14)
Net cash from investing activities	(355)	(152)
Cash Flows from Financing Activities:
Proceeds from long-term borrowings	2,716	1,202
Repayments on long-term borrowings	(3,287)	(1,859)
Proceeds from issuance of common stock	57	6
Debt financing costs	(20)	(16)
Net cash from financing activities	(534)	(667)
Effect of exchange rate changes on cash	31	(4)
Net change in cash	54	156
Cash and cash equivalents at beginning of period	750	750
Cash and cash equivalents at end of period	$ 804	$ 906

Basis of Presentation

Basis of Presentation	9 Months Ended
	Jul. 03, 2021
Basis of Presentation [Abstract]
Basis of Presentation	1. Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements of Berry Global Group, Inc. (“the Company,” “we,” or “Berry”) have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) pursuant to the rules and regulations of the Securities and Exchange Commission for interim reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts and disclosures at the date of the financial statements and during the reporting period. Actual results could differ from those estimates. The extra week in fiscal 2021 occurred in the first quarter. In October 2020, the Company reorganized portions of its operating segments in order to better align our various businesses for future growth. The Company has recast all prior period amounts to conform to this new reporting structure. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included, and all subsequent events up to the time of the filing have been evaluated. For further information, refer to the Company’s most recent Form 10-K filed with the Securities and Exchange Commission.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	9 Months Ended
	Jul. 03, 2021
Recent Accounting Pronouncements [Abstract]
Recent Accounting Pronouncements	2. Recent Accounting Pronouncements Credit Losses In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326) and issued subsequent amendments to the initial guidance. The new standard requires entities to measure all expected credit losses for most financial assets held at the reporting date based on an expected loss model, which includes historical experience, current conditions, and reasonable and supportable forecasts. The new standard also requires enhanced disclosure. The Company adopted the new standard beginning fiscal 2021 with no material impact to the Company’s consolidated financial statements. See Note 3. Revenue and Accounts Receivable. Defined Benefit Plans In August 2018, the FASB issued ASU 2018-14, Changes to the Disclosure Requirements for Defined Benefit Plans. The new standard removes requirements to disclose the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year and the effects of a one-percentage-point changes in assumed health care cost trend rates. The standard also adds requirements to disclose the reasons for significant gains and losses related to changes in the benefit obligations for the period and the accumulated benefit obligation (“ABO”) for plans with ABOs in excess of plan assets. The new standard will be effective for the Company beginning fiscal 2022. The Company is currently evaluating the impact of the adoption of this standard to our disclosures. Income Taxes In December 2019, the FASB issued ASU 2019-12, Income Taxes - Simplifying the Accounting for Income Taxes (Topic 740). The new guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other aspects of the accounting for income taxes. The new standard will be effective for the Company beginning fiscal 2022. The Company is currently evaluating the impact of the adoption of this standard to the Company’s consolidated financial statements. Reference Rate Reform In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform - Facilitation of the Effects of Reference Rate Reform on Financial Reporting (Topic 848). This standard provides temporary optional expedients and exceptions to the GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, such as SOFR. ASU 2020-04 is effective upon issuance and generally can be applied through the end of calendar year 2022. The Company is currently evaluating the impact and whether it plans to adopt the optional expedients and exceptions provided under this new standard.

Revenue and Accounts Receivable

Revenue and Accounts Receivable	9 Months Ended
	Jul. 03, 2021
Revenue and Accounts Receivable [Abstract]
Revenue	3. Revenue and Accounts Receivable Our revenues are primarily derived from the sale of plastic packaging products to customers. Revenue is recognized when performance obligations are satisfied, in an amount reflecting the consideration to which the Company expects to be entitled. We consider the promise to transfer products to be our sole performance obligation. If the consideration agreed to in a contract includes a variable amount, we estimate the amount of c onsideration we expect to be entitled to in exchange for transferring the promised goods to the customer using the most likely amount method. Our main source of variable consideration is customer rebates. There are no material instances where variable consideration is constrained and not recorded at the initial time of sale. Generally, our revenue is recognized at a point in time for standard promised goods at the time of shipment, when title and risk of loss pass to the customer. The
Accounts Receivable	Accounts receivable, net are presented net of allowance for credit losses of $22 million and $25 million at July 3, 2021 and September 26, 2020, respectively. The Company records its current expected credit losses based on a variety of factors including historical loss experience and current customer financial condition. The changes to our current expected credit losses, write-off activity, and recoveries were not material for any of the periods presented. The Company has entered into various qualifying factoring agreements to sell certain receivables to third-party financial institutions. The transfer of receivables is accounted for as a sale, without recourse. Net sales available under qualifying U.S. based programs were $290 million and $242 million for the quarterly periods ended July 3, 2021 and June 27, 2020, respectively. Net sales available under qualifying U.S. based programs were $ million and $ million for the ended and , respectively.

Dispositions

Dispositions	9 Months Ended
	Jul. 03, 2021
Dispositions [Abstract]
Dispositions	4. Dispositions During fiscal 2021, the Company completed the sale of its U.S. Flexible Packaging Converting business which was primarily operated in the Engineered Materials segment for net proceeds of $140 million and its non-core Czech Republic Reaction Injection Molding business which was operated in the Consumer Packaging International segment for net proceeds of $22 million. A net pretax loss on the divestitures of $22 million was recorded in fiscal 2021 within Restructuring and transaction activities on the Consolidated Statements of Income. The U.S. Flexible Packaging Converting business and the Czech Republic Reaction Injection Molding business recorded net sales during fiscal 2020 of $203 million and $41 million, respectively.

Restructuring and Transaction A

Restructuring and Transaction Activities	9 Months Ended
	Jul. 03, 2021
Restructuring and Transaction Activities [Abstract]
Restructuring and Transaction Activities	5. Restructuring and Transaction Activities The table below includes the significant components of restructuring and transaction activities, by reporting segment: Quarterly Period Ended Three Quarterly Periods Ended July 3, 2021 June 27, 2020 July 3, 2021 June 27, 2020 Consumer Packaging International $ 3 $ 14 $ 44 $ 37 Consumer Packaging North America — 2 1 6 Health, Hygiene & Specialties — 1 — 6 Engineered Materials 1 2 (4 ) 6 Consolidated $ 4 $ 19 $ 41 $ 55 The table below sets forth the activity with respect to the restructuring and transaction activities accrual at July 3, 2021: Restructuring Employee Severance and Benefits Facility Exit Costs Non-cash Impairment Charges Transaction Activities Total Balance as of September 26, 2020 $ 10 $ 7 $ — $ — $ 17 Charges 7 2 1 31 41 Non-cash items — — (1 ) (30 ) (31 ) Cash (14 ) (3 ) — (1 ) (18 ) Balance as of July 3, 2021 $ 3 $ 6 $ — $ — $ 9

Leases

Leases	9 Months Ended
	Jul. 03, 2021
Leases [Abstract]
Leases	6. Leases The Company leases certain manufacturing facilities, warehouses, office space, manufacturing equipment, office equipment, and automobiles. We recognize right-of-use assets and lease liabilities for leases with original lease terms greater than one year based on the present value of lease payments over the lease term using our incremental borrowing rate on a collateralized basis. Short-term leases, with original lease terms of less than one year, are not recognized on the balance sheet. We are party to certain leases, namely for manufacturing facilities, which offer renewal options to extend the original lease term. Renewal options are included in the right-of-use asset and lease liability based on our assessment of the probability that the options will be exercised. Supplemental lease information is as follows: Leases Classification July 3, 2021 September 26, 2020 Operating leases: Operating lease right-of-use assets Right-of-use assets $ 577 $ 562 Current operating lease liabilities Other current liabilities 114 115 Noncurrent operating lease liabilities Operating lease liability 480 464 Finance leases: Finance lease right-of-use assets Property, plant, and equipment, net $ 62 $ 78 Current finance lease liability Current portion of long-term debt 16 17 Noncurrent finance lease liabilities Long-term debt, less current portion 41 59 Cash paid for amounts included in lease liabilities Three Quarterly Periods Ended July 3, 2021 Three Quarterly Periods Ended June 27, 2020 Operating cash flows from operating leases $ 85 $ 86 Operating cash flows from finance leases 2 3 Financing cash flows from finance leases 19 25 Right-of-use assets obtained in exchange for new operating lease liabilities were $19 million and $53 million for the quarterly and three quarterly periods ended July 3, 2021, respectively.

Long-Term Debt

Long-Term Debt	9 Months Ended
	Jul. 03, 2021
Long-Term Debt [Abstract]
Long-Term Debt	7. Long-Term Debt Long-term debt consists of the following: Facility Maturity Date July 3, 2021 September 26, 2020 Term loan July 2026 $ 3,440 4,208 Revolving line of credit May 2024 — — 0.95 February 2024 800 — 1.00 (a) July 2025 829 814 1.57 January 2026 1,525 — 4.875 July 2026 1,250 1,250 1.65 January 2027 400 — 1.50 (a) July 2027 445 436 5.125 July 2023 200 300 4.50 February 2026 300 500 5.625 July 2027 500 500 Debt discounts and deferred fees (81 ) (85 ) Finance leases and other Various 86 121 Retired debt Various — 2,193 Total long-term debt 9,694 10,237 Current portion of long-term debt (225 ) (75 ) Long-term debt, less current portion $ 9,469 10,162 (a) Euro denominated In fiscal 2021, the Company issued $800 million aggregate principal amount of 0.95% first priority senior secured notes due 2024, $1,525 million aggregate principal amount of 1.57% first priority senior secured notes due 2026, and $400 million aggregate principal amount of 1.65% first priority senior secured notes due 2027. The proceeds were used to prepay a portion of the outstanding Term loans. Debt extinguishment costs of $26 million, primarily comprised of deferred debt discount and financing fees, were recorded in Other expense, net on the Consolidated Statements of Income upon the extinguishment of a portion of the Term loans and prepayments on the notes. Debt discounts and deferred financing fees are presented net of Long-term debt, less the current portion on the Consolidated Balance Sheets and are amortized to Interest expense, net on the Consolidated Statements of Income through maturity.

Financial Instruments and Fair

Financial Instruments and Fair Value Measurements	9 Months Ended
	Jul. 03, 2021
Financial Instruments and Fair Value Measurements [Abstract]
Financial Instruments and Fair Value Measurements	8. Financial Instruments and Fair Value Measurements In the normal course of business, the Company is exposed to certain risks arising from business operations and economic factors. The Company may use derivative financial instruments to help manage market risk and reduce the exposure to fluctuations in interest rates and foreign currencies. These financial instruments are not used for trading or other speculative purposes. Cross-Currency Swaps The Company is party to certain cross-currency swaps to hedge a portion of our foreign currency risk. The swap agreements mature May 2022 (€250 million), June 2024 (€1,625 million) and July 2027 (£700 million). In addition to cross-currency swaps, we hedge a portion of our foreign currency risk by designating foreign currency denominated long-term debt as net investment hedges of certain foreign operations. As of July 3, 2021, we had outstanding long-term debt of €785 million that was designated as a hedge of our net investment in certain euro-denominated foreign subsidiaries. When valuing cross-currency swaps the Company utilizes Level 2 inputs (substantially observable). Interest Rate Swaps The primary purpose of the Company’s interest rate swap activities is to manage interest expense variability associated with our outstanding variable rate term loan debt. When valuing interest rate swaps the Company utilizes Level 2 inputs (substantially observable). During fiscal 2021, the Company issued various fixed rate first priority senior secured notes and used the proceeds to prepay a portion of its variable rate Term loans. As a result, the Company de-designated a $1 billion interest rate swap transaction that was set to expire in June 2026. The amounts included in Accumulated other comprehensive loss at the date of de-designation are being amortized to Interest expense through the term of the original swap. As of July 3, 2021, the Company effectively had (i) a $450 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 1.398%, with an expiration in June 2026, (ii) a $400 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 1.916% with an expiration in June 2026, (iii) a $884 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 1.857%, with an expiration in June 2024, and (iv) a $473 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.050%, with an expiration in June 2024. The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized. Balances on a gross basis are as follows: Derivative Instruments Hedge Designation Balance Sheet Location July 3, 2021 September 26, 2020 Cross-currency swaps Designated Other long-term liabilities $ 419 $ 270 Interest rate swaps Designated Other long-term liabilities 92 226 Interest rate swaps Not designated Other long-term liabilities 53 — The effect of the Company’s derivative instruments on the Consolidated Statements of Income is as follows: Quarterly Period Ended Three Quarterly Periods Ended Derivative Instruments Statements of Income Location July 3, 2021 June 27, 2020 July 3, 2021 June 27, 2020 Cross-currency swaps Interest expense, net $ (2 ) $ (2 ) $ (6 ) $ (5 ) Interest rate swaps Interest expense, net 18 13 52 17 Non-recurring Fair Value Measurements The Company has certain assets that are measured at fair value on a non-recurring basis when impairment indicators are present or when the Company completes an acquisition. The Company adjusts certain long-lived assets to fair value only when the carrying values exceed the fair values. The categorization of the framework used to value the assets is considered Level 3, due to the subjective nature of the unobservable inputs used to determine the fair value. These assets that are subject to our annual impairment analysis primarily include our definite lived and indefinite lived intangible assets, including Goodwill and our property, plant and equipment. The Company reviews Goodwill and other indefinite lived assets for impairment as of the first day of the fourth fiscal quarter each year and more frequently if impairment indicators exist. The Company determined Goodwill and other indefinite lived assets were not impaired in our annual fiscal 2020 assessment. No impairment indicators were identified in the current quarter. Included in the following table are the major categories of assets measured at fair value on a non-recurring basis as of July 3, 2021 and September 26, 2020, along with the impairment loss recognized on the fair value measurement during the period: As of July 3, 2021 Level 1 Level 2 Level 3 Total Impairment Indefinite-lived trademarks $ — $ — $ 248 $ 248 $ — Goodwill — — 5,265 5,265 — Definite lived intangible assets — — 2,086 2,086 — Property, plant, and equipment — — 4,731 4,731 1 Total $ — $ — $ 12,330 $ 12,330 $ 1 As of September 26, 2020 Level 1 Level 2 Level 3 Total Impairment Indefinite-lived trademarks $ — $ — $ 248 $ 248 $ — Goodwill — — 5,173 5,173 — Definite lived intangible assets — — 2,249 2,249 — Property, plant, and equipment — — 4,561 4,561 2 Total $ — $ — $ 12,231 $ 12,231 $ 2 The Company’s financial instruments consist primarily of cash and cash equivalents, long-term debt, interest rate and cross-currency swap agreements, and finance lease obligations. The of our marketable long-term indebtedness exceeded by $ million as of . The Company’s long-term debt fair values were determined using Level 2 inputs (substantially observable).

Income Taxes

Income Taxes	9 Months Ended
	Jul. 03, 2021
Income Taxes [Abstract]
Income Taxes	9. Income Taxes In comparison to the statutory rate, the higher effective tax rate for the quarter and year-to-date was negatively impacted by state taxes and global intangible low-taxed income provisions.

Segment and Geographic Data

Segment and Geographic Data	9 Months Ended
	Jul. 03, 2021
Segment and Geographic Data [Abstract]
Segment and Geographic Data	10. Segment and Geographic Data The Company’s operations are organized into reporting segments: Consumer Packaging International, Consumer Packaging North America, Engineered Materials, and Health, Hygiene & Specialties. The structure is designed to align us with our customers, provide optimal service, drive future growth, and to facilitate synergies realization. Engineered Materials Consumer Packaging North America Consumer Packaging International Selected information by reportable segment is presented in the following tables: Quarterly Period Ended Three Quarterly Periods Ended July 3, 2021 June 27, 2020 July 3, 2021 June 27, 2020 Net sales: Consumer Packaging International $ 1,095 $ 904 $ 3,143 $ 2,804 Consumer Packaging North America 847 644 2,264 1,888 Health, Hygiene & Specialties 828 669 2,349 1,923 Engineered Materials 905 693 2,425 2,086 Total net sales $ 3,675 $ 2,910 $ 10,181 $ 8,701 Operating income: Consumer Packaging International $ 79 $ 80 $ 214 $ 176 Consumer Packaging North America 76 78 212 191 Health, Hygiene & Specialties 113 95 323 208 Engineered Materials 75 94 231 255 Total operating income $ 343 $ 347 $ 980 $ 830 Depreciation and amortization: Consumer Packaging International $ 88 $ 78 $ 258 $ 239 Consumer Packaging North America 53 58 164 174 Health, Hygiene & Specialties 43 45 130 138 Engineered Materials 28 28 87 87 Total depreciation and amortization $ 212 $ 209 $ 639 $ 638 Selected information by geographical region is presented in the following tables: Quarterly Period Ended Three Quarterly Periods Ended July 3, 2021 June 27, 2020 July 3, 2021 June 27, 2020 Net sales: United States and Canada $ 1,937 $ 1,430 $ 5,342 $ 4,648 Europe 1,308 1,172 3,658 3,156 Rest of world 430 308 1,181 897 Total net sales $ 3,675 $ 2,910 $ 10,181 $ 8,701 Selected information by product line is presented in the following tables: Quarterly Period Ended Three Quarterly Periods Ended July 3, 2021 June 27, 2020 July 3, 2021 June 27, 2020 Net sales: Packaging 81 83 80 82 Non-packaging 19 17 20 18 Consumer Packaging International 100 % 100 % 100 % 100 % Rigid Open Top 58 54 56 55 Rigid Closed Top 42 46 44 45 Consumer Packaging North America 100 % 100 % 100 % 100 % Health 19 19 19 16 Hygiene 47 47 46 48 Specialties 34 34 35 36 Health, Hygiene & Specialties 100 % 100 % 100 % 100 % Core Films 66 64 63 62 Retail & Industrial 34 36 37 38 Engineered Materials 100 % 100 % 100 % 100 %

Contingencies and Commitments

Contingencies and Commitments	9 Months Ended
	Jul. 03, 2021
Contingencies and Commitments [Abstract]
Contingencies and Commitments	11. Contingencies and Commitments The Company is party to various legal proceedings involving routine claims which are incidental to its business. Although the Company’s legal and financial liability with respect to such proceedings cannot be estimated with certainty, we believe that any ultimate liability would not be material to our financial statements. The Company has various purchase commitments for raw materials, supplies, and property and equipment incidental to the ordinary conduct of business.

Share Repurchase Program

Share Repurchase Program	9 Months Ended
	Jul. 03, 2021
Share Repurchase Program [Abstract]
Share Repurchase Program	12. Share Repurchase Program No shares were repurchased during the three quarterly periods ended July 3, 2021. Authorized share repurchases of $393 million remain available to the Company.

Basic and Diluted Net Income Pe

Basic and Diluted Net Income Per Share	9 Months Ended
	Jul. 03, 2021
Basic and Diluted Net Income Per Share [Abstract]
Basic and Diluted Net Income Per Share	13. Basic and Diluted Net Income Per Share Basic net income per share is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for common stock equivalents. Diluted net income per share is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common share equivalents outstanding for the period determined using the treasury-stock method and the if-converted method. For purposes of this calculation, stock options are considered to be common stock equivalents and are only included in the calculation of diluted net income per share when their effect is dilutive. No shares were excluded from the diluted net income per share calculation for the quarterly and three quarterly periods ended July 3, 2021. For the quarterly and three quarterly periods ended June 27, 2020, 7.1 million and 7.1 million shares, respectively, were excluded from the diluted net income per share calculation as their effect would be anti-dilutive. The following tables provide a reconciliation of the numerator and denominator of the basic and diluted net income per share calculations. Quarterly Period Ended Three Quarterly Periods Ended (in millions, except per share amounts) July 3, 2021 June 27, 2020 July 3, 2021 June 27, 2020 Numerator Consolidated net income $ 194 $ 191 $ 505 $ 364 Denominator Weighted average common shares outstanding - basic 135.1 132.5 134.3 132.4 Dilutive shares 3.4 1.7 3.4 1.9 Weighted average common and common equivalent shares outstanding - diluted 138.5 134.2 137.7 134.3 Per common share income Basic $ 1.44 $ 1.44 $ 3.76 $ 2.75 Diluted $ 1.40 $ 1.42 $ 3.67 $ 2.71

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
	Jul. 03, 2021
Accumulated Other Comprehensive Loss [Abstract]
Accumulated Other Comprehensive Loss	14. Accumulated Other Comprehensive Loss The components and activity of Accumulated other comprehensive loss are as follows: Quarterly Period Ended Currency Translation Defined Benefit Pension and Retiree Health Benefit Plans Derivative Instruments Accumulated Other Comprehensive Loss Balance at April 3, 2021 $ (173 ) $ (116 ) $ (86 ) $ (375 ) Other comprehensive income (loss) before reclassifications 91 — (5 ) 86 Net amount reclassified from accumulated other comprehensive loss — — 3 3 Balance at July 3, 2021 $ (82 ) $ (116 ) $ (88 ) $ (286 ) Currency Translation Defined Benefit Pension and Retiree Health Benefit Plans Derivative Instruments Accumulated Other Comprehensive Loss Balance at March 28, 2020 $ (344 ) $ (57 ) $ (147 ) $ (548 ) Other comprehensive loss before reclassifications 11 — (23 ) (12 ) Net amount reclassified from accumulated other comprehensive loss — — 10 10 Balance at June 27, 2020 $ (333 ) $ (57 ) $ (160 ) $ (550 ) Three Quarterly Periods Ended Currency Translation Defined Benefit Pension and Retiree Health Benefit Plans Derivative Instruments Accumulated Other Comprehensive Loss Balance at September 26, 2020 $ (278 ) $ (116 ) $ (157 ) $ (551 ) Other comprehensive income before reclassifications 196 — 62 258 Net amount reclassified from accumulated other comprehensive loss — — 7 7 Balance at July 3, 2021 $ (82 ) $ (116 ) $ (88 ) $ (286 ) Currency Translation Defined Benefit Pension and Retiree Health Benefit Plans Derivative Instruments Accumulated Other Comprehensive Loss Balance at September 28, 2019 $ (279 ) $ (56 ) $ (51 ) $ (386 ) Other comprehensive loss before reclassifications (54 ) (1 ) (126 ) (181 ) Net amount reclassified from accumulated other comprehensive loss — — 17 17 Balance at June 27, 2020 $ (333 ) $ (57 ) $ (160 ) $ (550 )

Basis of Presentation (Policies

Basis of Presentation (Policies)	9 Months Ended
	Jul. 03, 2021
Basis of Presentation [Abstract]
Basis of Presentation	The accompanying unaudited Condensed Consolidated Financial Statements of Berry Global Group, Inc. (“the Company,” “we,” or “Berry”) have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) pursuant to the rules and regulations of the Securities and Exchange Commission for interim reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.
Use of Estimates	In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts and disclosures at the date of the financial statements and during the reporting period. Actual results could differ from those estimates.
Reclassifications	The extra week in fiscal 2021 occurred in the first quarter. In October 2020, the Company reorganized portions of its operating segments in order to better align our various businesses for future growth. The Company has recast all prior period amounts to conform to this new reporting structure.

Recent Accounting Pronounceme_2

Recent Accounting Pronouncements (Policies)	9 Months Ended
	Jul. 03, 2021
Recent Accounting Pronouncements [Abstract]
Recent Accounting Pronouncements	Credit Losses In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326) and issued subsequent amendments to the initial guidance. The new standard requires entities to measure all expected credit losses for most financial assets held at the reporting date based on an expected loss model, which includes historical experience, current conditions, and reasonable and supportable forecasts. The new standard also requires enhanced disclosure. The Company adopted the new standard beginning fiscal 2021 with no material impact to the Company’s consolidated financial statements. See Note 3. Revenue and Accounts Receivable. Defined Benefit Plans In August 2018, the FASB issued ASU 2018-14, Changes to the Disclosure Requirements for Defined Benefit Plans. The new standard removes requirements to disclose the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year and the effects of a one-percentage-point changes in assumed health care cost trend rates. The standard also adds requirements to disclose the reasons for significant gains and losses related to changes in the benefit obligations for the period and the accumulated benefit obligation (“ABO”) for plans with ABOs in excess of plan assets. The new standard will be effective for the Company beginning fiscal 2022. The Company is currently evaluating the impact of the adoption of this standard to our disclosures. Income Taxes In December 2019, the FASB issued ASU 2019-12, Income Taxes - Simplifying the Accounting for Income Taxes (Topic 740). The new guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other aspects of the accounting for income taxes. The new standard will be effective for the Company beginning fiscal 2022. The Company is currently evaluating the impact of the adoption of this standard to the Company’s consolidated financial statements. Reference Rate Reform In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform - Facilitation of the Effects of Reference Rate Reform on Financial Reporting (Topic 848). This standard provides temporary optional expedients and exceptions to the GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, such as SOFR. ASU 2020-04 is effective upon issuance and generally can be applied through the end of calendar year 2022. The Company is currently evaluating the impact and whether it plans to adopt the optional expedients and exceptions provided under this new standard.

Restructuring and Transaction_2

Restructuring and Transaction Activities (Tables)	9 Months Ended
	Jul. 03, 2021
Restructuring and Transaction Activities [Abstract]
Restructuring Charges	The table below includes the significant components of restructuring and transaction activities, by reporting segment: Quarterly Period Ended Three Quarterly Periods Ended July 3, 2021 June 27, 2020 July 3, 2021 June 27, 2020 Consumer Packaging International $ 3 $ 14 $ 44 $ 37 Consumer Packaging North America — 2 1 6 Health, Hygiene & Specialties — 1 — 6 Engineered Materials 1 2 (4 ) 6 Consolidated $ 4 $ 19 $ 41 $ 55
Restructuring Accrual Activity	The table below sets forth the activity with respect to the restructuring and transaction activities accrual at July 3, 2021: Restructuring Employee Severance and Benefits Facility Exit Costs Non-cash Impairment Charges Transaction Activities Total Balance as of September 26, 2020 $ 10 $ 7 $ — $ — $ 17 Charges 7 2 1 31 41 Non-cash items — — (1 ) (30 ) (31 ) Cash (14 ) (3 ) — (1 ) (18 ) Balance as of July 3, 2021 $ 3 $ 6 $ — $ — $ 9

Leases (Tables)

Leases (Tables)	9 Months Ended
	Jul. 03, 2021
Leases [Abstract]
Lease Assets and Liabilities	Supplemental lease information is as follows: Leases Classification July 3, 2021 September 26, 2020 Operating leases: Operating lease right-of-use assets Right-of-use assets $ 577 $ 562 Current operating lease liabilities Other current liabilities 114 115 Noncurrent operating lease liabilities Operating lease liability 480 464 Finance leases: Finance lease right-of-use assets Property, plant, and equipment, net $ 62 $ 78 Current finance lease liability Current portion of long-term debt 16 17 Noncurrent finance lease liabilities Long-term debt, less current portion 41 59
Cash Paid for Amounts Included in Lease Liabilities	Cash paid for amounts included in lease liabilities Three Quarterly Periods Ended July 3, 2021 Three Quarterly Periods Ended June 27, 2020 Operating cash flows from operating leases $ 85 $ 86 Operating cash flows from finance leases 2 3 Financing cash flows from finance leases 19 25

Long-Term Debt (Tables)

Long-Term Debt (Tables)	9 Months Ended
	Jul. 03, 2021
Long-Term Debt [Abstract]
Long-Term Debt	Long-term debt consists of the following: Facility Maturity Date July 3, 2021 September 26, 2020 Term loan July 2026 $ 3,440 4,208 Revolving line of credit May 2024 — — 0.95 February 2024 800 — 1.00 (a) July 2025 829 814 1.57 January 2026 1,525 — 4.875 July 2026 1,250 1,250 1.65 January 2027 400 — 1.50 (a) July 2027 445 436 5.125 July 2023 200 300 4.50 February 2026 300 500 5.625 July 2027 500 500 Debt discounts and deferred fees (81 ) (85 ) Finance leases and other Various 86 121 Retired debt Various — 2,193 Total long-term debt 9,694 10,237 Current portion of long-term debt (225 ) (75 ) Long-term debt, less current portion $ 9,469 10,162 (a) Euro denominated

Financial Instruments and Fai_2

Financial Instruments and Fair Value Measurements (Tables)	9 Months Ended
	Jul. 03, 2021
Financial Instruments and Fair Value Measurements [Abstract]
Fair Value of Derivatives and Location on Consolidated Balance Sheets	The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized. Balances on a gross basis are as follows: Derivative Instruments Hedge Designation Balance Sheet Location July 3, 2021 September 26, 2020 Cross-currency swaps Designated Other long-term liabilities $ 419 $ 270 Interest rate swaps Designated Other long-term liabilities 92 226 Interest rate swaps Not designated Other long-term liabilities 53 —
Effect of Derivatives on Consolidated Statements of Income	The effect of the Company’s derivative instruments on the Consolidated Statements of Income is as follows: Quarterly Period Ended Three Quarterly Periods Ended Derivative Instruments Statements of Income Location July 3, 2021 June 27, 2020 July 3, 2021 June 27, 2020 Cross-currency swaps Interest expense, net $ (2 ) $ (2 ) $ (6 ) $ (5 ) Interest rate swaps Interest expense, net 18 13 52 17
Assets Measured at Fair Value on Non-recurring Basis	Included in the following table are the major categories of assets measured at fair value on a non-recurring basis as of July 3, 2021 and September 26, 2020, along with the impairment loss recognized on the fair value measurement during the period: As of July 3, 2021 Level 1 Level 2 Level 3 Total Impairment Indefinite-lived trademarks $ — $ — $ 248 $ 248 $ — Goodwill — — 5,265 5,265 — Definite lived intangible assets — — 2,086 2,086 — Property, plant, and equipment — — 4,731 4,731 1 Total $ — $ — $ 12,330 $ 12,330 $ 1 As of September 26, 2020 Level 1 Level 2 Level 3 Total Impairment Indefinite-lived trademarks $ — $ — $ 248 $ 248 $ — Goodwill — — 5,173 5,173 — Definite lived intangible assets — — 2,249 2,249 — Property, plant, and equipment — — 4,561 4,561 2 Total $ — $ — $ 12,231 $ 12,231 $ 2

Segment and Geographic Data (Ta

Segment and Geographic Data (Tables)	9 Months Ended
	Jul. 03, 2021
Segment and Geographic Data [Abstract]
Selected Information by Reportable Segment	Selected information by reportable segment is presented in the following tables: Quarterly Period Ended Three Quarterly Periods Ended July 3, 2021 June 27, 2020 July 3, 2021 June 27, 2020 Net sales: Consumer Packaging International $ 1,095 $ 904 $ 3,143 $ 2,804 Consumer Packaging North America 847 644 2,264 1,888 Health, Hygiene & Specialties 828 669 2,349 1,923 Engineered Materials 905 693 2,425 2,086 Total net sales $ 3,675 $ 2,910 $ 10,181 $ 8,701 Operating income: Consumer Packaging International $ 79 $ 80 $ 214 $ 176 Consumer Packaging North America 76 78 212 191 Health, Hygiene & Specialties 113 95 323 208 Engineered Materials 75 94 231 255 Total operating income $ 343 $ 347 $ 980 $ 830 Depreciation and amortization: Consumer Packaging International $ 88 $ 78 $ 258 $ 239 Consumer Packaging North America 53 58 164 174 Health, Hygiene & Specialties 43 45 130 138 Engineered Materials 28 28 87 87 Total depreciation and amortization $ 212 $ 209 $ 639 $ 638
Selected Information by Geographical Region	Selected information by geographical region is presented in the following tables: Quarterly Period Ended Three Quarterly Periods Ended July 3, 2021 June 27, 2020 July 3, 2021 June 27, 2020 Net sales: United States and Canada $ 1,937 $ 1,430 $ 5,342 $ 4,648 Europe 1,308 1,172 3,658 3,156 Rest of world 430 308 1,181 897 Total net sales $ 3,675 $ 2,910 $ 10,181 $ 8,701
Selected Information by Product Line	Selected information by product line is presented in the following tables: Quarterly Period Ended Three Quarterly Periods Ended July 3, 2021 June 27, 2020 July 3, 2021 June 27, 2020 Net sales: Packaging 81 83 80 82 Non-packaging 19 17 20 18 Consumer Packaging International 100 % 100 % 100 % 100 % Rigid Open Top 58 54 56 55 Rigid Closed Top 42 46 44 45 Consumer Packaging North America 100 % 100 % 100 % 100 % Health 19 19 19 16 Hygiene 47 47 46 48 Specialties 34 34 35 36 Health, Hygiene & Specialties 100 % 100 % 100 % 100 % Core Films 66 64 63 62 Retail & Industrial 34 36 37 38 Engineered Materials 100 % 100 % 100 % 100 %

Basic and Diluted Net Income _2

Basic and Diluted Net Income Per Share (Tables)	9 Months Ended
	Jul. 03, 2021
Basic and Diluted Net Income Per Share [Abstract]
Basic and Diluted Net Income Per Share	The following tables provide a reconciliation of the numerator and denominator of the basic and diluted net income per share calculations. Quarterly Period Ended Three Quarterly Periods Ended (in millions, except per share amounts) July 3, 2021 June 27, 2020 July 3, 2021 June 27, 2020 Numerator Consolidated net income $ 194 $ 191 $ 505 $ 364 Denominator Weighted average common shares outstanding - basic 135.1 132.5 134.3 132.4 Dilutive shares 3.4 1.7 3.4 1.9 Weighted average common and common equivalent shares outstanding - diluted 138.5 134.2 137.7 134.3 Per common share income Basic $ 1.44 $ 1.44 $ 3.76 $ 2.75 Diluted $ 1.40 $ 1.42 $ 3.67 $ 2.71

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Jul. 03, 2021
Accumulated Other Comprehensive Loss [Abstract]
Accumulated Other Comprehensive Loss	The components and activity of Accumulated other comprehensive loss are as follows: Quarterly Period Ended Currency Translation Defined Benefit Pension and Retiree Health Benefit Plans Derivative Instruments Accumulated Other Comprehensive Loss Balance at April 3, 2021 $ (173 ) $ (116 ) $ (86 ) $ (375 ) Other comprehensive income (loss) before reclassifications 91 — (5 ) 86 Net amount reclassified from accumulated other comprehensive loss — — 3 3 Balance at July 3, 2021 $ (82 ) $ (116 ) $ (88 ) $ (286 ) Currency Translation Defined Benefit Pension and Retiree Health Benefit Plans Derivative Instruments Accumulated Other Comprehensive Loss Balance at March 28, 2020 $ (344 ) $ (57 ) $ (147 ) $ (548 ) Other comprehensive loss before reclassifications 11 — (23 ) (12 ) Net amount reclassified from accumulated other comprehensive loss — — 10 10 Balance at June 27, 2020 $ (333 ) $ (57 ) $ (160 ) $ (550 ) Three Quarterly Periods Ended Currency Translation Defined Benefit Pension and Retiree Health Benefit Plans Derivative Instruments Accumulated Other Comprehensive Loss Balance at September 26, 2020 $ (278 ) $ (116 ) $ (157 ) $ (551 ) Other comprehensive income before reclassifications 196 — 62 258 Net amount reclassified from accumulated other comprehensive loss — — 7 7 Balance at July 3, 2021 $ (82 ) $ (116 ) $ (88 ) $ (286 ) Currency Translation Defined Benefit Pension and Retiree Health Benefit Plans Derivative Instruments Accumulated Other Comprehensive Loss Balance at September 28, 2019 $ (279 ) $ (56 ) $ (51 ) $ (386 ) Other comprehensive loss before reclassifications (54 ) (1 ) (126 ) (181 ) Net amount reclassified from accumulated other comprehensive loss — — 17 17 Balance at June 27, 2020 $ (333 ) $ (57 ) $ (160 ) $ (550 )

Basis of Presentation (Details)

Basis of Presentation (Details)	9 Months Ended
	Jul. 03, 2021Segment
Basis of Presentation [Abstract]
Number of operating segments	4

Revenue and Accounts Receivab_2

Revenue and Accounts Receivable (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 03, 2021	Jun. 27, 2020	Jul. 03, 2021	Jun. 27, 2020	Sep. 26, 2020
Revenue and Accounts Receivable [Abstract]
Accrual for customer rebates	$ 103		$ 103		$ 104
Allowance for credit losses	22		22		$ 25
Net sales available under qualifying U.S. based factoring agreements	290	$ 242	794	$ 700
Amounts due from financial institutions	$ 0	$ 0	$ 0	$ 0

Dispositions (Details)

Dispositions (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Jul. 03, 2021	Jun. 27, 2020	Jul. 03, 2021	Jun. 27, 2020	Sep. 26, 2020
Dispositions [Abstract]
Proceeds from sale of business			$ 165	$ 0
Net sales	$ 3,675	$ 2,910	10,181	$ 8,701
Restructuring and Transaction Activities [Member]
Dispositions [Abstract]
Net pretax loss on divestitures			(22)
U.S. Flexible Packaging Converting Business [Member]
Dispositions [Abstract]
Proceeds from sale of business			140
Net sales					$ 203
Non-core Czech Republic Reaction Injection Molding Business [Member]
Dispositions [Abstract]
Proceeds from sale of business			$ 22
Net sales					$ 41

Restructuring and Transaction_3

Restructuring and Transaction Activities, Restructuring Charges by Segment (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 03, 2021	Jun. 27, 2020	Jul. 03, 2021	Jun. 27, 2020
Restructuring Charges [Abstract]
Restructuring and transaction activities	$ 4	$ 19	$ 41	$ 55
Consumer Packaging International [Member]
Restructuring Charges [Abstract]
Restructuring and transaction activities	3	14	44	37
Consumer Packaging North America [Member]
Restructuring Charges [Abstract]
Restructuring and transaction activities	0	2	1	6
Health, Hygiene & Specialties [Member]
Restructuring Charges [Abstract]
Restructuring and transaction activities	0	1	0	6
Engineered Materials [Member]
Restructuring Charges [Abstract]
Restructuring and transaction activities	$ 1	$ 2	$ (4)	$ 6

Restructuring and Transaction_4

Restructuring and Transaction Activities, Restructuring Accrual Activity (Details) $ in Millions	9 Months Ended
	Jul. 03, 2021USD ($)
Restructuring Accrual [Roll Forward]
Balance at September 26, 2020	$ 17
Charges	41
Non-cash items	(31)
Cash	(18)
Balance at July 3, 2021	9
Employee Severance and Benefits [Member]
Restructuring Accrual [Roll Forward]
Balance at September 26, 2020	10
Charges	7
Non-cash items	0
Cash	(14)
Balance at July 3, 2021	3
Facility Exit Costs [Member]
Restructuring Accrual [Roll Forward]
Balance at September 26, 2020	7
Charges	2
Non-cash items	0
Cash	(3)
Balance at July 3, 2021	6
Non-Cash Impairment Charges [Member]
Restructuring Accrual [Roll Forward]
Balance at September 26, 2020	0
Charges	1
Non-cash items	(1)
Cash	0
Balance at July 3, 2021	0
Transaction Activities [Member]
Restructuring Accrual [Roll Forward]
Balance at September 26, 2020	0
Charges	31
Non-cash items	(30)
Cash	(1)
Balance at July 3, 2021	$ 0

Leases (Details)

Leases (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Jul. 03, 2021	Jul. 03, 2021	Jun. 27, 2020	Sep. 26, 2020
Operating Leases [Abstract]
Operating lease right-of-use assets	$ 577	$ 577		$ 562
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Operating lease right-of-use assets	Operating lease right-of-use assets		Operating lease right-of-use assets
Current operating lease liabilities	$ 114	$ 114		$ 115
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Other Liabilities, Current	Other Liabilities, Current		Other Liabilities, Current
Noncurrent operating lease liabilities	$ 480	$ 480		$ 464
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Noncurrent operating lease liabilities	Noncurrent operating lease liabilities		Noncurrent operating lease liabilities
Finance Leases [Abstract]
Finance lease right-of-use assets	$ 62	$ 62		$ 78
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Property, Plant and Equipment, Net	Property, Plant and Equipment, Net		Property, Plant and Equipment, Net
Current finance lease liability	$ 16	$ 16		$ 17
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]	Long-term Debt and Lease Obligation, Current	Long-term Debt and Lease Obligation, Current		Long-term Debt and Lease Obligation, Current
Noncurrent finance lease liabilities	$ 41	$ 41		$ 59
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Long-term debt, less current portion	Long-term debt, less current portion		Long-term debt, less current portion
Cash Paid for Amounts Included in Lease Liabilities [Abstract]
Operating cash flows from operating leases		$ 85	$ 86
Operating cash flows from finance leases		2	3
Financing cash flows from finance leases		19	$ 25
Right-of-use assets obtained in exchange for operating lease liabilities	$ 19	$ 53

Long-Term Debt, Summary (Detail

Long-Term Debt, Summary (Details) - USD ($) $ in Millions		9 Months Ended
		Jul. 03, 2021	Sep. 26, 2020
Long-term Debt [Abstract]
Debt discounts and deferred fees		$ (81)	$ (85)
Total long-term debt		9,694	10,237
Current portion of long-term debt		(225)	(75)
Long-term debt, less current portion		9,469	10,162
Term Loan due July 2026 [Member]
Long-term Debt [Abstract]
Long-term debt		$ 3,440	4,208
Maturity date		Jul. 31, 2026
Revolving Line of Credit [Member]
Long-term Debt [Abstract]
Long-term debt		$ 0	0
Maturity date		May 31, 2024
0.95% First Priority Senior Secured Notes [Member]
Long-term Debt [Abstract]
Long-term debt		$ 800	0
Interest rate		0.95%
Maturity date		Feb. 29, 2024
1.00% First Priority Senior Secured Notes [Member]
Long-term Debt [Abstract]
Long-term debt	[1]	$ 829	814
Interest rate		1.00%
Maturity date		Jul. 31, 2025
1.57% First Priority Senior Secured Notes [Member]
Long-term Debt [Abstract]
Long-term debt		$ 1,525	0
Interest rate		1.57%
Maturity date		Jan. 31, 2026
4.875% First Priority Senior Secured Notes [Member]
Long-term Debt [Abstract]
Long-term debt		$ 1,250	1,250
Interest rate		4.875%
Maturity date		Jul. 31, 2026
1.65% First Priority Senior Secured Notes [Member]
Long-term Debt [Abstract]
Long-term debt		$ 400	0
Interest rate		1.65%
Maturity date		Jan. 31, 2027
1.50% First Priority Senior Secured Notes [Member]
Long-term Debt [Abstract]
Long-term debt	[1]	$ 445	436
Interest rate		1.50%
Maturity date		Jul. 31, 2027
5.125% Second Priority Senior Secured Notes [Member]
Long-term Debt [Abstract]
Long-term debt		$ 200	300
Interest rate		5.125%
Maturity date		Jul. 31, 2023
4.50% Second Priority Senior Secured Notes [Member]
Long-term Debt [Abstract]
Long-term debt		$ 300	500
Interest rate		4.50%
Maturity date		Feb. 28, 2026
5.625% Second Priority Senior Secured Notes [Member]
Long-term Debt [Abstract]
Long-term debt		$ 500	500
Interest rate		5.625%
Maturity date		Jul. 31, 2027
Finance Leases and Other [Member]
Long-term Debt [Abstract]
Long-term debt		$ 86	121
Retired Debt [Member]
Long-term Debt [Abstract]
Long-term debt		$ 0	$ 2,193
[1]	Euro denominated

Long-Term Debt, Fiscal 2021 Act

Long-Term Debt, Fiscal 2021 Activity (Details) $ in Millions	9 Months Ended
	Jul. 03, 2021USD ($)
0.95% First Priority Senior Secured Notes [Member]
Long-Term Debt [Abstract]
Face amount of debt issued	$ 800
Interest rate	0.95%
1.57% First Priority Senior Secured Notes [Member]
Long-Term Debt [Abstract]
Face amount of debt issued	$ 1,525
Interest rate	1.57%
1.57% First Priority Senior Secured Notes [Member] | Other Expense, Net [Member]
Long-Term Debt [Abstract]
Debt extinguishment costs	$ 26
1.65% First Priority Senior Secured Notes [Member]
Long-Term Debt [Abstract]
Face amount of debt issued	$ 400
Interest rate	1.65%

Financial Instruments and Fai_3

Financial Instruments and Fair Value Measurements, Cross-Currency Swaps (Details) - Jul. 03, 2021 € in Millions, £ in Millions	EUR (€)	GBP (£)
Euro Denominated [Member]
Cross-Currency Swaps [Abstract]
Long-term debt	€ 785
Cross-Currency Swap Maturing May 2022 [Member]
Cross-Currency Swaps [Abstract]
Notional amount of swap	250
Cross-Currency Swap Maturing June 2024 [Member]
Cross-Currency Swaps [Abstract]
Notional amount of swap	€ 1,625
Cross-Currency Swap Maturing July 2027 [Member]
Cross-Currency Swaps [Abstract]
Notional amount of swap | £		£ 700

Financial Instruments and Fai_4

Financial Instruments and Fair Value Measurements, Interest Rate Swaps (Details) $ in Millions	9 Months Ended
	Jul. 03, 2021USD ($)
Interest Rate Swap Expiring June 2026 [Member]
Interest Rate Swaps [Abstract]
Notional amount of swap	$ 1,000
Interest Rate Swap Expiring June 2026 [Member]
Interest Rate Swaps [Abstract]
Notional amount of swap	$ 450
Fixed annual rate of swap	1.398%
Interest Rate Swap Expiring June 2026 [Member] | LIBOR [Member]
Interest Rate Swaps [Abstract]
Term of variable rate	1 month
Interest Rate Swap Expiring June 2026 [Member]
Interest Rate Swaps [Abstract]
Notional amount of swap	$ 400
Fixed annual rate of swap	1.916%
Interest Rate Swap Expiring June 2026 [Member] | LIBOR [Member]
Interest Rate Swaps [Abstract]
Term of variable rate	1 month
Interest Rate Swap Expiring June 2024 [Member]
Interest Rate Swaps [Abstract]
Notional amount of swap	$ 884
Fixed annual rate of swap	1.857%
Interest Rate Swap Expiring June 2024 [Member] | LIBOR [Member]
Interest Rate Swaps [Abstract]
Term of variable rate	1 month
Interest Rate Swap Expiring June 2024 [Member]
Interest Rate Swaps [Abstract]
Notional amount of swap	$ 473
Fixed annual rate of swap	2.05%
Interest Rate Swap Expiring June 2024 [Member] | LIBOR [Member]
Interest Rate Swaps [Abstract]
Term of variable rate	1 month

Financial Instruments and Fai_5

Financial Instruments and Fair Value Measurements, Fair Value of Derivative and Location on Consolidated Balance Sheets (Details) - Other Long-Term Liabilities [Member] - USD ($) $ in Millions	Jul. 03, 2021	Sep. 26, 2020
Cross-Currency Swaps [Member] | Designated [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	$ 419	$ 270
Interest Rate Swaps [Member] | Designated [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	92	226
Interest Rate Swaps [Member] | Not Designated [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	$ 53	$ 0

Financial Instruments and Fai_6

Financial Instruments and Fair Value Measurements, Effect of Derivatives on Consolidated Statements of Income (Details) - Interest Expense, Net [Member] - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 03, 2021	Jun. 27, 2020	Jul. 03, 2021	Jun. 27, 2020
Cross-Currency Swaps [Member]
Derivative Instruments [Abstract]
Loss (gain) on derivative instruments	$ (2)	$ (2)	$ (6)	$ (5)
Interest Rate Swaps [Member]
Derivative Instruments [Abstract]
Loss (gain) on derivative instruments	$ 18	$ 13	$ 52	$ 17

Financial Instruments and Fai_7

Financial Instruments and Fair Value Measurements, Assets Measured at Fair Value on Non-Recurring Basis (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Jul. 03, 2021	Sep. 26, 2020
Impairment [Abstract]
Indefinite lived trademarks	$ 0	$ 0
Goodwill	0	0
Definite lived intangible assets	0	0
Property, plant and equipment	1	2
Impairment charges	1	2
Fair Value Adjustment [Abstract]
Fair value of long-term indebtedness greater/(less) than book value	126
Fair Value on Nonrecurring Basis [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	248	248
Goodwill	5,265	5,173
Definite lived intangible assets	2,086	2,249
Property, plant and equipment	4,731	4,561
Total	12,330	12,231
Fair Value on Nonrecurring Basis [Member] | Level 1 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	0	0
Goodwill	0	0
Definite lived intangible assets	0	0
Property, plant and equipment	0	0
Total	0	0
Fair Value on Nonrecurring Basis [Member] | Level 2 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	0	0
Goodwill	0	0
Definite lived intangible assets	0	0
Property, plant and equipment	0	0
Total	0	0
Fair Value on Nonrecurring Basis [Member] | Level 3 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	248	248
Goodwill	5,265	5,173
Definite lived intangible assets	2,086	2,249
Property, plant and equipment	4,731	4,561
Total	$ 12,330	$ 12,231

Segment and Geographic Data, Se

Segment and Geographic Data, Selected Information by Reportable Segment (Details) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 03, 2021USD ($)	Jun. 27, 2020USD ($)	Jul. 03, 2021USD ($)Segment	Jun. 27, 2020USD ($)
Segment and Geographic Data [Abstract]
Number of reporting segments | Segment			4
Selected Information by Reportable Segment [Abstract]
Net sales	$ 3,675	$ 2,910	$ 10,181	$ 8,701
Operating income	343	347	980	830
Depreciation and amortization	212	209	639	638
Consumer Packaging International [Member] | North American Healthcare Business [Member]
Selected Information by Reportable Segment [Abstract]
Net sales				216
Consumer Packaging International [Member] | European Films Business [Member]
Selected Information by Reportable Segment [Abstract]
Net sales				(537)
Consumer Packaging North America [Member] | North American Healthcare Business [Member]
Selected Information by Reportable Segment [Abstract]
Net sales				(216)
Health, Hygiene & Specialties [Member] | Tapes Business [Member]
Selected Information by Reportable Segment [Abstract]
Net sales				199
Engineered Materials [Member] | Tapes Business [Member]
Selected Information by Reportable Segment [Abstract]
Net sales				(199)
Engineered Materials [Member] | European Films Business [Member]
Selected Information by Reportable Segment [Abstract]
Net sales				537
Operating Segment [Member] | Consumer Packaging International [Member]
Selected Information by Reportable Segment [Abstract]
Net sales	1,095	904	3,143	2,804
Operating income	79	80	214	176
Depreciation and amortization	88	78	258	239
Operating Segment [Member] | Consumer Packaging North America [Member]
Selected Information by Reportable Segment [Abstract]
Net sales	847	644	2,264	1,888
Operating income	76	78	212	191
Depreciation and amortization	53	58	164	174
Operating Segment [Member] | Health, Hygiene & Specialties [Member]
Selected Information by Reportable Segment [Abstract]
Net sales	828	669	2,349	1,923
Operating income	113	95	323	208
Depreciation and amortization	43	45	130	138
Operating Segment [Member] | Engineered Materials [Member]
Selected Information by Reportable Segment [Abstract]
Net sales	905	693	2,425	2,086
Operating income	75	94	231	255
Depreciation and amortization	$ 28	$ 28	$ 87	$ 87

Segment and Geographic Data, _2

Segment and Geographic Data, Selected Information by Geographical Region (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 03, 2021	Jun. 27, 2020	Jul. 03, 2021	Jun. 27, 2020
Selected Information by Geography [Abstract]
Net sales	$ 3,675	$ 2,910	$ 10,181	$ 8,701
Reportable Geography [Member] | United States and Canada [Member]
Selected Information by Geography [Abstract]
Net sales	1,937	1,430	5,342	4,648
Reportable Geography [Member] | Europe [Member]
Selected Information by Geography [Abstract]
Net sales	1,308	1,172	3,658	3,156
Reportable Geography [Member] | Rest of World [Member]
Selected Information by Geography [Abstract]
Net sales	$ 430	$ 308	$ 1,181	$ 897

Segment and Geographic Data, _3

Segment and Geographic Data, Selected Information by Product Line (Details) - Net Sales [Member] - Product Concentration Risk [Member]	3 Months Ended		9 Months Ended
	Jul. 03, 2021	Jun. 27, 2020	Jul. 03, 2021	Jun. 27, 2020
Consumer Packaging International [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	100.00%	100.00%	100.00%	100.00%
Consumer Packaging International [Member] | Packaging [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	81.00%	83.00%	80.00%	82.00%
Consumer Packaging International [Member] | Non-packaging [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	19.00%	17.00%	20.00%	18.00%
Consumer Packaging North America [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	100.00%	100.00%	100.00%	100.00%
Consumer Packaging North America [Member] | Rigid Open Top [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	58.00%	54.00%	56.00%	55.00%
Consumer Packaging North America [Member] | Rigid Closed Top [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	42.00%	46.00%	44.00%	45.00%
Health, Hygiene & Specialties [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	100.00%	100.00%	100.00%	100.00%
Health, Hygiene & Specialties [Member] | Health [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	19.00%	19.00%	19.00%	16.00%
Health, Hygiene & Specialties [Member] | Hygiene [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	47.00%	47.00%	46.00%	48.00%
Health, Hygiene & Specialties [Member] | Specialties [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	34.00%	34.00%	35.00%	36.00%
Engineered Materials [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	100.00%	100.00%	100.00%	100.00%
Engineered Materials [Member] | Core Films [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	66.00%	64.00%	63.00%	62.00%
Engineered Materials [Member] | Retail & Industrial [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	34.00%	36.00%	37.00%	38.00%

Share Repurchase Program (Detai

Share Repurchase Program (Details) $ in Millions	9 Months Ended
	Jul. 03, 2021USD ($)shares
Share Repurchase Program [Abstract]
Number of shares repurchased (in shares) | shares	0
Remaining amount of share repurchase program | $	$ 393

Basic and Diluted Net Income _3

Basic and Diluted Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Jul. 03, 2021	Jun. 27, 2020	Jul. 03, 2021	Jun. 27, 2020
Numerator [Abstract]
Consolidated net income	$ 194	$ 191	$ 505	$ 364
Denominator [Abstract]
Weighted average common shares outstanding - basic (in shares)	135.1	132.5	134.3	132.4
Dilutive shares (in shares)	3.4	1.7	3.4	1.9
Weighted average common and common equivalent shares outstanding - diluted (in shares)	138.5	134.2	137.7	134.3
Per Common Share Income [Abstract]
Basic (in dollars per share)	$ 1.44	$ 1.44	$ 3.76	$ 2.75
Diluted (in dollars per share)	$ 1.40	$ 1.42	$ 3.67	$ 2.71
Stock Options [Member]
Basic and Diluted Net Income Per Share [Abstract]
Antidilutive shares excluded from computation of earnings per share (in shares)	0	7.1	0	7.1

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 03, 2021	Jun. 27, 2020	Jul. 03, 2021	Jun. 27, 2020
Accumulated Other Comprehensive Loss [Roll Forward]
Other comprehensive income (loss) before reclassifications	$ 86	$ (12)	$ 258	$ (181)
Net amount reclassified from accumulated other comprehensive loss	3	10	7	17
Accumulated Other Comprehensive Loss [Member]
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	(375)	(548)	(551)	(386)
Ending balance	(286)	(550)	(286)	(550)
Currency Translation [Member]
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	(173)	(344)	(278)	(279)
Other comprehensive income (loss) before reclassifications	91	11	196	(54)
Net amount reclassified from accumulated other comprehensive loss	0	0	0	0
Ending balance	(82)	(333)	(82)	(333)
Defined Benefit Pension and Retiree Health Benefit Plans [Member]
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	(116)	(57)	(116)	(56)
Other comprehensive income (loss) before reclassifications	0	0	0	(1)
Net amount reclassified from accumulated other comprehensive loss	0	0	0	0
Ending balance	(116)	(57)	(116)	(57)
Derivative Instruments [Member]
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	(86)	(147)	(157)	(51)
Other comprehensive income (loss) before reclassifications	(5)	(23)	62	(126)
Net amount reclassified from accumulated other comprehensive loss	3	10	7	17
Ending balance	$ (88)	$ (160)	$ (88)	$ (160)